± HEALTH Objective To evaluate the accuracy, completeness, clarity, source transparency, and readability of leading AI…+ HEALTH Background Early prediction of in-hospital mortality in critically ill patients can aid clinicians in optimiz…+ HEALTH Hypertension is a major risk factor for cardiovascular diseases, with changes in gut microbiota composition a…+ SCIENCE Fire ants (Solenopsis spp. Westwood) pose a major ecological and economic threat, mainly due to the invasive…± HEALTH Objectives The current study aimed to quantify the diagnostic accuracy of commonly utilized chatbots includin…+ HEALTH Objective Despite elevated risk for epilepsy following traumatic brain injury (TBI), there are limited tools…± HEALTH Timely and accurate diagnosis of ST-elevation myocardial infarction (STEMI) is critical in military operation…+ HEALTH Colorectal cancer (CRC) exhibits substantial metabolic heterogeneity. This study developed a robust prognosti…
TruaceTracing the truth around AIWednesday, August 5, 2026
Subscribe
TRV-2026-0599Certified recordPeer-reviewed

Innovative approaches to therapeutic target discovery amid the global challenge of antimicrobial resistance

Antimicrobial resistance is a constant threat to global public health, requiring innovative strategies for therapeutic target identification. Hence, this narrative review discusses the application of structural modeling and artificial intelligence in the functional prediction of proteins encoded by multidrug-resistant bacterial genomes. Tools such as AlphaFold and RoseTTAFold have enabled high-accuracy three-dimensional structure prediction, facilitating the annotation of hypothetical proteins and the identifica…

Health · The Trace — both readings · certified 2026-07-31 · v1 · article view · machine-readable

Current reading — gain

Structural modeling tools such as AlphaFold and RoseTTAFold enable high-accuracy 3D prediction of proteins encoded by multidrug-resistant bacterial genomes, facilitating functional annotation and accelerating design of new antimicrobial compounds.

Current reading — problem

AI-driven modeling for antimicrobial resistance target discovery continues to face persistent challenges around experimental validation and genomic variability, limiting confirmation of predicted functions.

What this doesn’t fix

Review notes persistent challenges regarding experimental validation and genomic variability that limit translation of AI-predicted structures into validated therapeutic targets.

Evidence

Reader signal

How should this claim be treated?

Cite this record

Truvace Impact Record TRV-2026-0599, v1: “Innovative approaches to therapeutic target discovery amid the global challenge of antimicrobial resistance.” Truvace, 2026-07-31. /record/TRV-2026-0599 (accessed at citation time). sha256 da8e4f4631b79fd4…

Calibration history

Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.

  1. Certifiedv1da8e4f4631b7…

    Certified into the record

Verify this record
How to verify without trusting this page

Fetch the canonical text of any version from /api/record/TRV-2026-0599 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.